- Previous Close
0.0004 - Open
0.0005 - Bid 0.0005 x --
- Ask 0.0006 x --
- Day's Range
0.0005 - 0.0007 - 52 Week Range
0.0003 - 0.0300 - Volume
56,634,999 - Avg. Volume
35,775,295 - Market Cap (intraday)
1.391M - Beta (5Y Monthly) 54.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. The company is based in Scottsdale, Arizona.
lbcbioscienceinc.com3
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CBDL
View More
Performance Overview: CBDL
Trailing total returns as of 11/19/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CBDL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CBDL
View MoreValuation Measures
Market Cap
938.49k
Enterprise Value
938.49k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-60.21%
Return on Assets (ttm)
--
Return on Equity (ttm)
-45.08%
Revenue (ttm)
178.45k
Net Income Avi to Common (ttm)
-107.44k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
82
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: CBDL
View MoreCompany Insights: CBDL
CBDL does not have Company Insights